Satish Kumar Aryan

Title: **Satish Kumar Aryan: Innovator in Pharmaceutical Chemistry**

Introduction

Satish Kumar Aryan is a notable inventor located in Kurukshetra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative approaches to drug preparation.

Latest Patents

Satish Kumar Aryan holds a patent for the "Process for the preparation of clopidogrel and its pharmaceutically acceptable salts." This invention outlines a process that involves the resolution of racemic methyl alpha-5-(4,5,6,7-tetrahydro[3,2-c]thienopyridyl)(2-chlorophenyl)-acetate, utilizing the salt formation with levorotatory camphor-10-sulfonic acid. The method aims to achieve a maximum yield of the camphor sulphonate salt of methyl S-(+)-alpha-5-(4,5,6,7-tetrahydro[3,2-c]thienopyridyl)(2-chlorophenyl)-acetate, which is subsequently transformed into clopidogrel or its pharmaceutically acceptable salts.

Career Highlights

Satish is employed at Ranbaxy Laboratories, Inc., where he has contributed to various projects aimed at enhancing drug efficacy and safety. His groundbreaking work in the pharmaceutical industry positions him as a key figure in developing new therapeutic agents.

Collaborations

In his career, Satish Kumar Aryan has collaborated with esteemed colleagues, including Parendn Dhirajlal Rathod and Ram Chander Aryan. These collaborations have furthered the scope of his research and development efforts, fostering innovation within the company.

Conclusion

With his impressive patent portfolio and collaborative spirit, Satish Kumar Aryan is a vital innovator in the field of pharmaceutical chemistry. His work continues to impact the development of essential medications, cementing his legacy as an inventor dedicated to improving healthcare outcomes.